The reporter indicated that the surgeon implanted a 12.6mm vticm5 -12.00/+1.50/012 (sphere/cylinder/axis), implantable collamer lens into the patient's right eye (od) on (b)(6) 2024.The patient underwent same day bilateral icl implantation.Opegan ovd was used intraoperatively.Toxic anterior segment syndrome (tass) was observed bilaterally same day upon lens implantation.Inflammation was confirmed by (b)(6) imaging.In the reporter's opinion, the cause is unknown.Additional information has been requested but none has been forthcoming.The lens remains implanted.
|
H6 - work order search: no similar complaint type events were reported for units within the same lot.Manufacturer's narrative: a review of the device labeling was completed.Iritis and cells in the anterior chamber are identified in the labeling as known potential adverse events following icl implantation.The dfu provides the surgeon instruction for complete ovd removal.Precaution: (6) after inserting this product, aspirate the viscoelastic substance completely from inside the eye.Do not use highly viscous viscoelastic substances that are difficult to aspirate completely.Toxic anterior segment syndrome (tass) is an acute sterile postoperative inflammation that can occur after uncomplicated or complicated intraocular surgery.While improper sterilization and contamination of surgical instruments remains the most common risk factor associated with tass, ocular viscoelastic, and improper preparation of antibiotics for intracameral injection may also lead to tass.An exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors.Requests for additional information has not been forthcoming.Claim # (b)(4).
|